Responses
Emerging technology, pharmacology and Therapetics
Original research
Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study
Compose a Response to This Article
Other responses
No responses have been published for this article.